In addition, earlier studies suggest MEG3 was downregulated in NAFLD models [14, 15]; however, no studies have examined the potential crosstalk between MEG3 and EZH2 in NAFLD. Here, EZH2 is linked to metabolic dysfunction-associated steatotic liver disease.